Paul Edward Kelly - 09 Sep 2024 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role: Director
Signature: /s/ Paul Kelly
Issuer symbol: RLMD
Transactions as of: 09 Sep 2024
Net transactions value: +$64,750
Form type: 4
Filing time: 11 Sep 2024, 17:46:26 UTC
Previous filing: 29 May 2024
Next filing: 20 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RLMD	Common Stock	Purchase	$64,750	+25,000	+13%	$2.59	212,295	09 Sep 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
F2	Purchase prices range from $2.50 to $2.64 per share, inclusive.

Content

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.

Purchase prices range from $2.50 to $2.64 per share, inclusive.